Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral laxatives after hip fracture surgery
2024-513871-42-00Phase 4Completed
- Sponsor
- University Hospital Odense
- Start
- Oct 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in constipation and hip fracture comparing Macrogol combinations regimen, Bisacodyl regimen and Combination macrogol + bisacodyl regimen (3 arms). Primary endpoint: Rescue laxative use by 72 hours. Started Oct 2024; status: completed.
02
Drugs
macrogolbisacodyl
03
Conditions
constipationhip fracture
Beyond the preview
Go deeper on 2024-513871-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513871-42-00.